Pep Therapy

2 known investors

PEP-Therapy is a biotechnology company developing peptide-based cancer therapeutics, with a lead product PEP-010 targeting cancers such as pancreatic and ovarian cancer. Its drug candidate induces apoptosis in cancer cells and has received FDA Orphan Drug Designation for pancreatic cancer.